BMS-540215 ≥95%

Supplier: ADIPOGEN CORP MS

Synonyms: (R)-1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol, Brivanib

SYN-1134-M001 SYN-1134-M005 SYN-1134-M010 SYN-1134-M050
102992-272EA 149.54 USD
102992-272 102992-274 102992-276 102992-278
BMS-540215 ≥95%
Brivanib (BMS-540215)

BMS-540215 is an ATP-competitive inhibitor of human VEGFR-2, with an IC(50) of 25nM and Ki of 26nM. BMS-540215 also showed good selectivity for FGFR-1 (IC(50) of 48nM), FGFR-2 (IC(50) of 125nM), and FGFR-3 (IC(50) of 68nM).

Formula: C₁₉H₁₉FN₄O₃
MW: 370.4 g/mol
Storage Temperature: Freezer
MDL Number: MFCD13194684
CAS Number: 649735-46-6

Order Now

Specification Test Results

Purity 95%
Appearance/Color Solid.
Solubility Soluble in DMSO or ethanol.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR